AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.HIV/AIDS Medical Practice Guidelines Now Available in a Mobile-Optimized Format
We are pleased to announce that the HIV/AIDS medical practice guidelines are now available in a mobile-optimized format! You can now view the guidelines in an easy-to-read format on your phone or tablet on the AIDSinfo mobile site. A new left menu allows you to easily navigate between different guideline sections, and a search function allows you to quickly find specific information within each guideline. Currently, the Adult and Adolescent Antiretroviral (ARV) Guidelines, Pediatric ARV Guidelines, Perinatal ARV Guidelines, and the Adult and Adolescent Opportunistic Infection (OI) Prevention and Treatment Guidelines are av...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 20, 2013 Category: Infectious Diseases Source Type: news
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Accepting Nominations for New Scientific/Clinical Members
The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise/practice in HIV clinical research and clinical care.
Panel members critically evaluate new information and prepare guideline revisions. The Panel is seeking new members available to serve a 4-year term beginning in March 2014, with potential for reappointment for an additional term.
Nominations must be received by October 11, 2013.
For more information and instructions reg...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 20, 2013 Category: Infectious Diseases Source Type: news
Recent HIV/AIDS News from NIH
August 30, 2013: NIH Observes 20th Anniversary of Women’s Interagency HIV Study
“The largest and longest-running study to investigate the impact of HIV on women in the United States marks its 20th anniversary this month. Findings from the Women’s Interagency HIV Study (WIHS) have helped define how best to treat HIV-infected women in the United States and globally.”
Read the NIH press release.
August 29, 2013: 2013 Avant-Garde Awards Explore HIV Without AIDS, Protective Genes
“With proposals ranging from a combined cocaine/HIV vaccine to unlocking...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 6, 2013 Category: Infectious Diseases Source Type: news
September 18 is National HIV/AIDS and Aging Awareness Day
National HIV/AIDS and Aging Awareness Day is a day set aside each year to recognize the impact of HIV/AIDS among older adults. According to the U.S. Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, in the United States, approximately 30% of people currently living with HIV/AIDS are 50 years of age or older. The number of older adults with HIV is growing for two reasons:
Antiretroviral therapy, which helps people infected with HIV live longer
An increase in newly diagnosed infections in people 50 years of age or older
Explore ou...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 6, 2013 Category: Infectious Diseases Source Type: news
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Accepting Nominations for New Scientific/Clinical Members
The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise/practice in HIV clinical research and clinical care.
Panel members critically evaluate new information and prepare guideline revisions. The Panel is seeking new members available to serve a 4-year term beginning in March 2014, with potential for reappointment for an additional term.
Nominations must be received by October 11, 2013.
For more information and instructions reg...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 6, 2013 Category: Infectious Diseases Source Type: news
Study Evaluates Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with a Plasmid IL-12 Vaccine and the Impact of Intramuscular Electroporation for Delivery
This study illustrates the power of combined DNA approaches to generate impressive immune responses in humans.”
More information is available:
PubMed: Study abstract
ClinicalTrials.gov: HVTN 070 study summary
ClinicalTrials.gov: HVTN 080 study summary (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 23, 2013 Category: Infectious Diseases Source Type: news
FDA Reopening Comment Period for Notice of Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research
“FDA is reopening the comment period for the notice of public meeting entitled ‘Human Immunodeficiency Virus (HIV) Patient-Focused Drug Development and HIV Cure Research,’ published in the Federal Register of May 21, 2013. As part of Patient-Focused Drug Development, FDA is gathering input from HIV patients and patient advocates on current approaches to managing HIV, symptoms experienced because of HIV or its treatment, and patient perspectives related to ‘HIV cure research.’
“Comments can be submitted until September 3, 2013.”
For more information and to learn how to submit comm...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 23, 2013 Category: Infectious Diseases Source Type: news
NIH-Funded Study Suggests Current Antiretroviral Drug Regimens May Protect Against Puberty Delays in HIV-Infected Children
“For children who have been HIV-infected since birth, current anti-HIV drug regimens may protect against the delays in puberty that had been seen in HIV-infected children taking older regimens, according to researchers funded by the National Institutes of Health.
“HIV appears to delay puberty. Among children born before 1990, more than 10 percent of HIV-positive girls and boys had not entered puberty by 12 and 13 years of age, respectively. However, a study published in the journal AIDS has found that puberty was delayed for less than 1 percent of children born since 1997, when more effective anti-HIV drug the...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 16, 2013 Category: Infectious Diseases Source Type: news
U.S. Public Health Service Updates Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
The U.S. Public Health Service (USPHS) recently updated recommendations for the management of health care personnel who experience occupational exposures to blood and/or other body fluids that might contain HIV and recommendations for HIV postexposure prophylaxis (PEP). For a summary of the recommendations, read the PubMed abstract. A link to the entire guideline is available below the abstract. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 16, 2013 Category: Infectious Diseases Source Type: news
FDA Approves Dolutegravir, a New Drug to Treat HIV-1 Infection
“The U.S. Food and Drug Administration today [August 12, 2013] approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection.
“Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply. It is a pill taken daily in combination with other antiretroviral drugs.
“Tivicay is approved for use in a broad population of HIV-infected patients. It can be used to treat HIV-infected adults who have never taken HIV therapy (treatment-naïve) and HIV-infected adults who have previously taken HIV therapy (treatment-experienced), includ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 16, 2013 Category: Infectious Diseases Source Type: news
CDC Webpage Offers Information on Preexposure Prophylaxis (PrEP)
CDC recently updated the “Basic Information on PrEP” webpage. The webpage offers helpful, easy-to-understand information on preexposure prophylaxis, or PrEP, which is a prevention option for people who are at high risk of getting HIV. Topics include why a person may want to consider taking PrEP, how well PrEP works, and how a person can start PrEP. For more information, visit the CDC PrEP webpage. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 9, 2013 Category: Infectious Diseases Source Type: news
FDA Approves First Rapid Diagnostic Test for Simultaneous Detection of HIV-1 Antigen and Both HIV-1 and HIV-2 Antibodies
“The U.S. Food and Drug Administration today [August 8, 2013] approved the first rapid Human Immunodeficiency Virus (HIV) test for the simultaneous detection of HIV-1 p24 antigen as well as antibodies to both HIV-1 and HIV-2 in human serum, plasma, and venous or fingerstick whole blood specimens. Approved for use as an aid in the diagnosis of HIV-1 and HIV-2 infection, the Alere Determine HIV-1/2 Ag/Ab Combo test is also the first FDA-approved test that independently distinguishes results for HIV-1 p24 antigen and HIV antibodies in a single test.
“The test can be used by trained professionals in outreach sett...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - August 9, 2013 Category: Infectious Diseases Source Type: news
“Drugs That Fight HIV” Brochure Recently Updated
NIAID recently updated the “Drugs That Fight HIV” brochure, which features images of FDA-approved antiretroviral medications, grouped by drug class and clearly identified by both generic and brand names. The brochure can be used by health care professionals when discussing HIV treatment with patients.
The brochure includes the addition of three drugs:
Rilpivirine (brand name: Edurant), a non-nucleoside reverse transcriptase inhibitor (NNRTI), approved May 2011.
Emtricitabine/rilpivirine/tenofovir (brand name: Complera), a combination drug, approved August 2011.
Elvitegravir/cobicistat/emt...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 26, 2013 Category: Infectious Diseases Source Type: news
NIH Study Suggests Antiretroviral Drugs in Pregnancy Are Not Linked to Children’s Language Delays
"The combinations of anti-HIV drugs recommended for pregnant women do not appear in general to increase their children’s risk for language delay, according to a study from a National Institutes of Health research network.
“Children exposed to HIV in the womb and whose mothers received combinations of anti-HIV drugs during pregnancy were no more likely to have language delays than were children exposed to HIV in the womb and whose mothers did not receive these recommended treatments, the study found. In both groups, about 25 percent of the children had language delays by 2 years of age, suggesting that the...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 26, 2013 Category: Infectious Diseases Source Type: news
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents document was published in an electronic format that could be easily updated as relevant changes in prevention and treatment recommendations occur.
The editors and subject matter experts are committed to timely changes in this document because so many health care providers, patients, and policy experts rely on this source for vital clinical information.
All changes are developed by the subject matter groups listed in the document (changes in group composition are also promptly posted). These changes are revi...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - July 8, 2013 Category: Infectious Diseases Source Type: news
